These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 23423222

  • 1. RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.
    Sun D, Haddad R, Kraniak JM, Horne SD, Tainsky MA.
    Mol Cancer Res; 2013 Jun; 11(6):616-27. PubMed ID: 23423222
    [Abstract] [Full Text] [Related]

  • 2. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ, Lee SJ, Sohn YB, Jin HS, Han JH, Kim YB, Yim H, Jeong SY.
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [Abstract] [Full Text] [Related]

  • 3. Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.
    Ahsan S, Ge Y, Tainsky MA.
    Oncotarget; 2016 Aug 30; 7(35):57171-57185. PubMed ID: 27494873
    [Abstract] [Full Text] [Related]

  • 4. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 5. R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.
    Weber SM, Brossier NM, Prechtl A, Barnes S, Wilson LS, Brosius SN, Longo JF, Carroll SL.
    Cell Commun Signal; 2021 Sep 16; 19(1):95. PubMed ID: 34530870
    [Abstract] [Full Text] [Related]

  • 6. Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression.
    Su W, Sin M, Darrow A, Sherman LS.
    Glia; 2003 Jun 16; 42(4):350-8. PubMed ID: 12730955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
    Park GH, Park E, Lee SJ, Lim K, Kim J, Park JE, Jeong SY.
    Int J Mol Sci; 2024 Aug 27; 25(17):. PubMed ID: 39273214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.
    Kraniak JM, Sun D, Mattingly RR, Reiners JJ, Tainsky MA.
    Mol Cell Biochem; 2010 Nov 27; 344(1-2):267-76. PubMed ID: 20680410
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.
    Clin Cancer Res; 2013 Jan 15; 19(2):450-61. PubMed ID: 23209032
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
    Barkan B, Kloog Y, Ehrlich M.
    Mol Cancer Ther; 2011 Aug 15; 10(8):1317-26. PubMed ID: 21632464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.